Medicare Enrolled

Dr. Edwin Youngstrom, D.O.

Urology Physician · Bakersfield, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
3838 SAN DIMAS ST STE B231, Bakersfield, CA 93301
6616650505
In practice since 2011 (14 years)
NPI: 1992091748 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Youngstrom from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Youngstrom? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Youngstrom

Dr. Edwin Youngstrom is an urology physician in Bakersfield, CA, with 14 years of NPI registration. Based on federal Medicare data, Dr. Youngstrom performed 1,582 Medicare services across 1,090 unique beneficiaries.

Between the years covered by Open Payments, Dr. Youngstrom received a total of $1,434 from 30 pharmaceutical and/or device companies across 59 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Youngstrom is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years in practice ▲ Top 45% volume in CA $1,434 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,582
Medicare services
Top 45% in CA for urology physician
1,090
Unique beneficiaries
$88
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~113 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
324 $99 $376
Urinalysis, manual
A manual laboratory examination of a urine sample to check for various substances and cells.
211 $3 $11
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
154 $68 $265
Leuprolide acetate (for depot suspension), 7.5 mg 150 $134 $711
Ceftriaxone antibiotic injection
This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered.
130 $0 $9
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
129 $124 $515
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
94 $204 $650
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
90 $141 $524
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
47 $139 $629
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
30 $28 $126
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
29 $11 $85
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
26 $77 $339
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
24 $42 $166
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
23 $63 $225
Bladder irrigation and/or instillation
This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder.
18 $65 $265
Ultrasound guidance for needle placement
Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure.
18 $47 $688
Ureteral stone crushing with stent insertion
An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open.
15 $323 $1,399
Prostate gland biopsy
A procedure to remove small samples of tissue from the prostate gland for laboratory examination.
15 $205 $690
Transrectal ultrasound of the pelvis
An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures.
15 $119 $302
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
14 $98 $324
Endoscopic removal of kidney or ureter stone
A procedure to remove or manipulate a stone in the kidney or ureter using an endoscope. The endoscope is a thin, lighted tube inserted into the body to visualize and treat the stone.
13 $43 $1,190
New patient office visit, complex (60-74 min) 13 $178 $681
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.9% high complexity
15.0% medium
84.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$1,434
Total received (2018-2024)
Avg $205/year across 7 years
Bottom 41% in CA for urology physician
30
Companies
59
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,312 (91.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$122 (8.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$17
2023
$55
2022
$70
2021
$46
2020
$330
2019
$490
2018
$426

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$17
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$191
Endo Pharmaceuticals Inc.
$145
Olympus America Inc.
$140
Coloplast Corp
$122
Dendreon Pharmaceuticals LLC
$104
IsoRay, Inc
$70
Avadel Specialty Pharmaceuticals, LLC
$59
Blue Earth Diagnostics Limited
$57
Janssen Biotech, Inc.
$52
Photocure Inc
$45
Astellas Pharma US Inc
$42
UROGEN PHARMA, INC.
$36
Teleflex LLC
$36
Intuitive Surgical, Inc.
$28
Allergan, Inc.
$27
AstraZeneca Pharmaceuticals LP
$25
Allergan Inc.
$24
NeoTract Inc.
$23
Janssen Pharmaceuticals, Inc
$22
Daiichi Sankyo Inc.
$21
Richard Wolf Medical Instruments Corp.
$19
Ethicon US, LLC
$19
AbbVie, Inc.
$19
Shire North American Group Inc
$19
Medtronic USA, Inc.
$18
Retrophin, Inc.
$16
Bayer HealthCare Pharmaceuticals Inc.
$16
Axonics, Inc.
$14
Axonics Modulation Technologies, Inc.
$14
PFIZER INC.
$13
Top 3 companies account for 33.2% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ALTIS · AMS · AURA · AVEED · Axonics r-SNM System · Axumin · BOTOX · Brachytherapy Source · CONTINENCE CARE · Cysview · Da Vinci Surgical System · ERLEADA · Erleada · GATTEX · GENERAL BPH · INJECTAFER · INTERSTIM · JELMYTO · LITHOVUE · Lumenis Pulse 120H · Lupron · MYRBETRIQ · Noctiva · Nubeqa · Olympus Camera Heads · PROVENGE · STRATAFIX · TAGRISSO · UROLIFT · UroLift · XIAFLEX · XTANDI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an urology physician in Bakersfield?
Compare urology physicians in the Bakersfield area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
11
Per 100K population
1.2
County median income
$67,660
Nearest hospital
BAKERSFIELD MEMORIAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Youngstrom is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Youngstrom experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Youngstrom performed 324 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Youngstrom receive payments from pharmaceutical companies?
Yes. Dr. Youngstrom received a total of $1,434 from 30 companies across 59 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Youngstrom's costs compare to other urology physicians in Bakersfield?
Dr. Youngstrom's average Medicare payment per service is $88. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Youngstrom) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →